Selena Gomez, founder of Rare Impact Fund

About Us Our Founder

Recording artist, actress, producer, entrepreneur, and philanthropist, Selena Gomez has been a leading voice in mental health for over a decade. With unflinching honesty, she shared her personal struggles in the 2022 film My Mind & Me, and consciously works to destigmatize the subject by discussing her mental health journey openly in the media. Selena’s experiences inspired her to establish her beauty brand, Rare Beauty, as a safe, welcoming community for young people everywhere. With The Rare Impact Fund, she aims to create real and lasting change.

As part of this effort, 1% of all Rare Beauty sales are donated to the Rare Impact Fund. In addition, the Rare Impact Fund raises funds from philanthropic foundations, individuals, corporate partners, and the community.

What We Do The Rare Impact Fund is:

Mobilizing $100 million in philanthropic dollars to distribute to trusted organizations that align with our vision and mission

Sourcing and vetting non-profit partners in mental health to reach more young people and inform the field

Connecting our donor community to a growing cohort of mental health organizations to increase social capital

Raising awareness and de-stigmatizing youth mental health

To Buy Clindamycin No Insurance Visit Our Pharmacy ↓

The Role of Clindamycin in Treating Infections

More seriously, it can lead to Clostridioides difficile-associated diarrhea, a severe intestinal condition. By targeting the bacterial protein synthesis process, it halts the proliferation of harmful bacteria, offering substantial relief to patients while showcasing its pivotal role in infection management. It effectively targets Streptococcus and Staphylococcus species, including some methicillin-resistant Staphylococcus aureus (MRSA) strains. Unlike some antibiotics, clindamycin's oral and intravenous forms offer flexibility in treatment, enhancing patient compliance. Clindamycin works its antibacterial magic by interfering with the protein synthesis mechanisms of pathogenic bacteria. Clindamycin stands out as a formidable antibiotic known for its versatility in tackling various bacterial infections. The integration of clindamycin into synergistic combination therapies aims to enhance its potency while reducing the risk of resistance.

Side Effects and Resistance: Challenges in Clindamycin Usage

The future of clindamycin research holds promise as scientists continue to explore these groundbreaking approaches. Clindamycin's ability to penetrate tissues extensively allows it to effectively address infections that other antibiotics may struggle to reach, making it a preferred choice for many clinicians. Developed in the 1960s, it belongs to the lincosamide class and has been employed to combat Gram-positive bacteria and some anaerobes. By binding to the 50S subunit of the bacterial ribosome, clindamycin effectively obstructs the necessary transfer of amino acids, a vital process for protein construction and bacterial growth. Renowned for its broad-spectrum activity, clindamycin stands out in the antibiotic arsenal by tackling a range of Gram-positive bacteria. Its unique ability to target bacteria responsible for conditions such as skin infections, respiratory infections, and certain types of bone infections underscores its clinical relevance. Researchers are investigating novel formulations to improve its bioavailability and efficacy against resistant strains.

Mechanisms of Action: Targeting Bacterial Protein Synthesis

Recent advancements in clindamycin research are paving the way for enhanced therapeutic applications. Clindamycin emerges as a frontline warrior in combating various bacterial infections, renowned for its efficacy in treating skin and soft tissue infections, as well as certain respiratory infections. These side effects necessitate careful patient monitoring and informed decision-making by healthcare providers. This interruption halts the production of essential proteins, which are fundamental to bacterial survival and proliferation. Patients taking clindamycin may experience side effects such as diarrhea, nausea, and abdominal pain. Among these innovations are nano-carrier systems that ensure targeted delivery, mitigating potential side effects. This antibiotic's prowess also extends to anaerobic bacteria like Clostridium perfringens, known to trigger severe infections.

Understanding Clindamycin: a Potent Antibiotic Force

Clindamycin, while effective, is not without challenges. Additionally, efforts are being made to understand the genetic mechanisms behind bacterial resistance, which could lead to the development of next-generation antibiotics. . . . . .

Spectrum of Efficacy: Bacteria Clindamycin Fights

. . . . . . .

Future Prospects: Advancements in Clindamycin Research

. . . . . . .

Order Paxil Online
Purchase Renova Online
Tobradex For Sale

Driving more dollars to an underfunded field

According to recent data, 62% of young people who have struggled with their mental health are not getting the complete care they need.

Recent data also tells us that global governments are allocating only 2% of their budgets toward mental health, and only 34% of responding countries indicated that their financial needs had been met.

As global governments come up short, private donations are proving to be essential. Yet just 0.5% of global health philanthropic spend went to mental health in 2021, according to WHO.

The Rare Impact Fund bridges the gap between donors and non-profits to generate much-needed financial support for mental health. Chief among priorities is supporting non-profits providing services to underrepresented populations as we recognize that mental health disparities among young people who are Black, Indigenous, and/or people of color (BIPOC), and LGBTQ+. are severely under resourced. The Rare Impact Fund portfolio is currently 40% BIPOC-led; globally, 20% of our non-profit partners are managed by leaders of color.

The Rare Impact Fund is shifting donor attention to non-profits making a tangible difference in the mental health space, ultimately changing the way they allocate funding.

Expanding access to mental health resources through data

Access to care is a challenge for Gen Z, too. A 2022 Kaiser Family Foundation survey found that almost half (47%) of young adults ages 18 to 29 did not get mental health care in the past year when they thought they might need it, with cost cited among the top barriers.

The Rare Impact Fund collects and analyzes quantitative and qualitative data from our non-profit partners to inform our approach to delivering grants and resources.

We monitor the progress of our non-profit partners to assess ways to optimize their impact. This approach to measurement provides donors and prospective partners insight into the most powerful ways to deploy funding. Our aim is to continue expanding access to youth mental health resources by stretching each dollar to its maximum potential.